Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery — Oct 9th, 2024

Smith & Nephew UK Ltd Patented technology further personalizes total knee arthroplasty for surgeons and patients Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has signed a co-marketing agreement with JointVue for its patented OrthoSonic™ 3D ...

SNN Stock May Gain Following the Co-Marketing Deal With JointVue — Oct 15th, 2024

Smith & Nephew SNATS SNN recently announced the signing of a co-marketing agreement with JointVue for its patented OrthoSonic 3D Surgery Planning Technology, which is the only ultrasound device currently on the market to deliver 3D preoperative planning. JointVue’s technology allows sur...

UK Value Stocks That Might Be Priced Below Intrinsic Estimates In October 2024 — Oct 16th, 2024

The United Kingdom market has remained flat over the last week but is up 6.5% over the past year, with earnings forecasted to grow by 14% annually. In this environment, identifying stocks that may be priced below their intrinsic value can offer investors potential opportunities for growth ...

Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery — Oct 9th, 2024

Smith & Nephew UK Ltd Patented technology further personalizes total knee arthroplasty for surgeons and patients Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has signed a co-marketing agreement with JointVue for its patented OrthoSonic™ 3D ...

RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design — Oct 16th, 2024

Smith & Nephew UK Ltd Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System has won the Red Dot Award for Design Concept 2024 in the Medical Devices and Technology Category, recogn...

Smith+Nephew raises the bar in knee revisions by launching new LEGION™ Hinged Knee System with OXINIUM™ Technology — Oct 2nd, 2024

Smith & Nephew UK Ltd Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announced today that its LEGION Hinged Knee (HK) System is now available in the United States with proprietary OXINIUM (Oxidized Zirconium) implant technology that delivers the durability of metal...

SNN Boosts Knee Revision Surgery With Its LEGION Hinged Knee System — Oct 11th, 2024

Smith & Nephew SNATS SNN recently launched its LEGION Hinged Knee System, which incorporates its proprietary OXINIUM Technology. The launch marks a significant advancement in the field of knee revisions, with the new system designed to improve the outcomes for patients requiring complex kn...

Should You Consider Adding Smith & Nephew plc (SNN) to Your Portfolio? — Oct 14th, 2024

Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned 8.24% in the quarter compared to the Russell Midcap Value Index’s 10.1% return. Stock s...

RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design — Oct 16th, 2024

Smith & Nephew UK Ltd Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System has won the Red Dot Award for Design Concept 2024 in the Medical Devices and Technology Category, recogn...

SNN Boosts Knee Revision Surgery With Its LEGION Hinged Knee System — Oct 11th, 2024

Smith & Nephew SNATS SNN recently launched its LEGION Hinged Knee System, which incorporates its proprietary OXINIUM Technology. The launch marks a significant advancement in the field of knee revisions, with the new system designed to improve the outcomes for patients requiring complex kn...

SNN Stock May Gain Following the Co-Marketing Deal With JointVue — Oct 15th, 2024

Smith & Nephew SNATS SNN recently announced the signing of a co-marketing agreement with JointVue for its patented OrthoSonic 3D Surgery Planning Technology, which is the only ultrasound device currently on the market to deliver 3D preoperative planning. JointVue’s technology allows sur...

UK Value Stocks That Might Be Priced Below Intrinsic Estimates In October 2024 — Oct 16th, 2024

The United Kingdom market has remained flat over the last week but is up 6.5% over the past year, with earnings forecasted to grow by 14% annually. In this environment, identifying stocks that may be priced below their intrinsic value can offer investors potential opportunities for growth ...

SNN Stock May Gain Following the Co-Marketing Deal With JointVue — Oct 15th, 2024

Smith & Nephew SNATS SNN recently announced the signing of a co-marketing agreement with JointVue for its patented OrthoSonic 3D Surgery Planning Technology, which is the only ultrasound device currently on the market to deliver 3D preoperative planning. JointVue’s technology allows sur...

UK Value Stocks That Might Be Priced Below Intrinsic Estimates In October 2024 — Oct 16th, 2024

The United Kingdom market has remained flat over the last week but is up 6.5% over the past year, with earnings forecasted to grow by 14% annually. In this environment, identifying stocks that may be priced below their intrinsic value can offer investors potential opportunities for growth ...

SNN Boosts Knee Revision Surgery With Its LEGION Hinged Knee System — Oct 11th, 2024

Smith & Nephew SNATS SNN recently launched its LEGION Hinged Knee System, which incorporates its proprietary OXINIUM Technology. The launch marks a significant advancement in the field of knee revisions, with the new system designed to improve the outcomes for patients requiring complex kn...

Should You Consider Adding Smith & Nephew plc (SNN) to Your Portfolio? — Oct 14th, 2024

Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned 8.24% in the quarter compared to the Russell Midcap Value Index’s 10.1% return. Stock s...

Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery — Oct 9th, 2024

Smith & Nephew UK Ltd Patented technology further personalizes total knee arthroplasty for surgeons and patients Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has signed a co-marketing agreement with JointVue for its patented OrthoSonic™ 3D ...

Should You Consider Adding Smith & Nephew plc (SNN) to Your Portfolio? — Oct 14th, 2024

Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned 8.24% in the quarter compared to the Russell Midcap Value Index’s 10.1% return. Stock s...

RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design — Oct 16th, 2024

Smith & Nephew UK Ltd Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System has won the Red Dot Award for Design Concept 2024 in the Medical Devices and Technology Category, recogn...

UK Value Stocks That Might Be Priced Below Intrinsic Estimates In October 2024 — Oct 16th, 2024

The United Kingdom market has remained flat over the last week but is up 6.5% over the past year, with earnings forecasted to grow by 14% annually. In this environment, identifying stocks that may be priced below their intrinsic value can offer investors potential opportunities for growth ...

SNN Stock May Gain Following the Co-Marketing Deal With JointVue — Oct 15th, 2024

Smith & Nephew SNATS SNN recently announced the signing of a co-marketing agreement with JointVue for its patented OrthoSonic 3D Surgery Planning Technology, which is the only ultrasound device currently on the market to deliver 3D preoperative planning. JointVue’s technology allows sur...

SNN Stock May Gain Following the Co-Marketing Deal With JointVue — Oct 15th, 2024

Smith & Nephew SNATS SNN recently announced the signing of a co-marketing agreement with JointVue for its patented OrthoSonic 3D Surgery Planning Technology, which is the only ultrasound device currently on the market to deliver 3D preoperative planning. JointVue’s technology allows sur...

SNN Stock May Gain Following the Co-Marketing Deal With JointVue — Oct 15th, 2024

Smith & Nephew SNATS SNN recently announced the signing of a co-marketing agreement with JointVue for its patented OrthoSonic 3D Surgery Planning Technology, which is the only ultrasound device currently on the market to deliver 3D preoperative planning. JointVue’s technology allows sur...

RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design — Oct 16th, 2024

Smith & Nephew UK Ltd Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System has won the Red Dot Award for Design Concept 2024 in the Medical Devices and Technology Category, recogn...

Smith & Nephew (LSE:SN.) Undervalued Despite Strong Financials and Strategic Alliances for Growth — Oct 2nd, 2024

Smith & Nephew (LSE:SN.) is navigating a dynamic period marked by both opportunities and challenges. Recent highlights include a notable 31.2% increase in dividend payouts and innovative product launches, juxtaposed against a 16.7% drop in Q2 net sales and inflationary pressures. In the di...

SNN Stock May Gain Following the Co-Marketing Deal With JointVue — Oct 15th, 2024

Smith & Nephew SNATS SNN recently announced the signing of a co-marketing agreement with JointVue for its patented OrthoSonic 3D Surgery Planning Technology, which is the only ultrasound device currently on the market to deliver 3D preoperative planning. JointVue’s technology allows sur...

Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery — Oct 9th, 2024

Smith & Nephew UK Ltd Patented technology further personalizes total knee arthroplasty for surgeons and patients Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has signed a co-marketing agreement with JointVue for its patented OrthoSonic™ 3D ...

RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design — Oct 16th, 2024

Smith & Nephew UK Ltd Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System has won the Red Dot Award for Design Concept 2024 in the Medical Devices and Technology Category, recogn...

Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery — Oct 9th, 2024

Smith & Nephew UK Ltd Patented technology further personalizes total knee arthroplasty for surgeons and patients Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has signed a co-marketing agreement with JointVue for its patented OrthoSonic™ 3D ...

UK Value Stocks That Might Be Priced Below Intrinsic Estimates In October 2024 — Oct 16th, 2024

The United Kingdom market has remained flat over the last week but is up 6.5% over the past year, with earnings forecasted to grow by 14% annually. In this environment, identifying stocks that may be priced below their intrinsic value can offer investors potential opportunities for growth ...

Should You Consider Adding Smith & Nephew plc (SNN) to Your Portfolio? — Oct 14th, 2024

Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned 8.24% in the quarter compared to the Russell Midcap Value Index’s 10.1% return. Stock s...

SNN Boosts Knee Revision Surgery With Its LEGION Hinged Knee System — Oct 11th, 2024

Smith & Nephew SNATS SNN recently launched its LEGION Hinged Knee System, which incorporates its proprietary OXINIUM Technology. The launch marks a significant advancement in the field of knee revisions, with the new system designed to improve the outcomes for patients requiring complex kn...

UK Value Stocks That Might Be Priced Below Intrinsic Estimates In October 2024 — Oct 16th, 2024

The United Kingdom market has remained flat over the last week but is up 6.5% over the past year, with earnings forecasted to grow by 14% annually. In this environment, identifying stocks that may be priced below their intrinsic value can offer investors potential opportunities for growth ...

Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery — Oct 9th, 2024

Smith & Nephew UK Ltd Patented technology further personalizes total knee arthroplasty for surgeons and patients Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has signed a co-marketing agreement with JointVue for its patented OrthoSonic™ 3D ...

RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design — Oct 16th, 2024

Smith & Nephew UK Ltd Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System has won the Red Dot Award for Design Concept 2024 in the Medical Devices and Technology Category, recogn...

Should You Consider Adding Smith & Nephew plc (SNN) to Your Portfolio? — Oct 14th, 2024

Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned 8.24% in the quarter compared to the Russell Midcap Value Index’s 10.1% return. Stock s...

SNN Boosts Knee Revision Surgery With Its LEGION Hinged Knee System — Oct 11th, 2024

Smith & Nephew SNATS SNN recently launched its LEGION Hinged Knee System, which incorporates its proprietary OXINIUM Technology. The launch marks a significant advancement in the field of knee revisions, with the new system designed to improve the outcomes for patients requiring complex kn...

RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design — Oct 16th, 2024

Smith & Nephew UK Ltd Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System has won the Red Dot Award for Design Concept 2024 in the Medical Devices and Technology Category, recogn...

Should You Consider Adding Smith & Nephew plc (SNN) to Your Portfolio? — Oct 14th, 2024

Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned 8.24% in the quarter compared to the Russell Midcap Value Index’s 10.1% return. Stock s...

Should You Consider Adding Smith & Nephew plc (SNN) to Your Portfolio? — Oct 14th, 2024

Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned 8.24% in the quarter compared to the Russell Midcap Value Index’s 10.1% return. Stock s...

Should You Consider Adding Smith & Nephew plc (SNN) to Your Portfolio? — Oct 14th, 2024

Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned 8.24% in the quarter compared to the Russell Midcap Value Index’s 10.1% return. Stock s...

UK Value Stocks That Might Be Priced Below Intrinsic Estimates In October 2024 — Oct 16th, 2024

The United Kingdom market has remained flat over the last week but is up 6.5% over the past year, with earnings forecasted to grow by 14% annually. In this environment, identifying stocks that may be priced below their intrinsic value can offer investors potential opportunities for growth ...

SNN Stock May Gain Following the Co-Marketing Deal With JointVue — Oct 15th, 2024

Smith & Nephew SNATS SNN recently announced the signing of a co-marketing agreement with JointVue for its patented OrthoSonic 3D Surgery Planning Technology, which is the only ultrasound device currently on the market to deliver 3D preoperative planning. JointVue’s technology allows sur...

RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design — Oct 16th, 2024

Smith & Nephew UK Ltd Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System has won the Red Dot Award for Design Concept 2024 in the Medical Devices and Technology Category, recogn...

SNN Boosts Knee Revision Surgery With Its LEGION Hinged Knee System — Oct 11th, 2024

Smith & Nephew SNATS SNN recently launched its LEGION Hinged Knee System, which incorporates its proprietary OXINIUM Technology. The launch marks a significant advancement in the field of knee revisions, with the new system designed to improve the outcomes for patients requiring complex kn...

Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery — Oct 9th, 2024

Smith & Nephew UK Ltd Patented technology further personalizes total knee arthroplasty for surgeons and patients Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has signed a co-marketing agreement with JointVue for its patented OrthoSonic™ 3D ...

Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery — Oct 9th, 2024

Smith & Nephew UK Ltd Patented technology further personalizes total knee arthroplasty for surgeons and patients Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has signed a co-marketing agreement with JointVue for its patented OrthoSonic™ 3D ...

SNN Boosts Knee Revision Surgery With Its LEGION Hinged Knee System — Oct 11th, 2024

Smith & Nephew SNATS SNN recently launched its LEGION Hinged Knee System, which incorporates its proprietary OXINIUM Technology. The launch marks a significant advancement in the field of knee revisions, with the new system designed to improve the outcomes for patients requiring complex kn...

UK Value Stocks That Might Be Priced Below Intrinsic Estimates In October 2024 — Oct 16th, 2024

The United Kingdom market has remained flat over the last week but is up 6.5% over the past year, with earnings forecasted to grow by 14% annually. In this environment, identifying stocks that may be priced below their intrinsic value can offer investors potential opportunities for growth ...

SNN Boosts Knee Revision Surgery With Its LEGION Hinged Knee System — Oct 11th, 2024

Smith & Nephew SNATS SNN recently launched its LEGION Hinged Knee System, which incorporates its proprietary OXINIUM Technology. The launch marks a significant advancement in the field of knee revisions, with the new system designed to improve the outcomes for patients requiring complex kn...